Introduction
Extreme high bone mass (HBM) may be monogenic (e.g. due to mutations in SOST or LRP5), oligogenic or polygenic, and may be due to variants in the same genes determining bone mineral density (BMD) as are found in the general population 1 .
Conclusions
Within our UK-based population association of unexplained extreme HBM showed overrepresentation in the 56 established BMD genes.
Results suggest HBM is, at least in part, of polygenic origin and is controlled by the same genes which determine BMD in the general population.
Studying extreme populations will enhance understanding of such genes determining BMD.
Whole-exome sequencing of this HBM population is currently underway to determine the exact variants contributing to HBM.
Study populations
Cases: (1) 258 unexplained HBM cases were recruited from 15 UK centres, by screening 335,115 DXA scans 2 .
• HBM was defined as either: a) L1 Z-score≥+3.2 plus total hip Z-score ≥+1. 
Aim
To determine the extent to which variation in 56 established BMD-associated loci cause raised BMD in an extreme UK-based HBM population.
GWAS Methods
We performed a GWAS for HBM, genotyping 240 unrelated HBM cases using Infinium OmniExpress-12v1.0 DNA analysis beadchips and clustering using GenomeStudio software (Illumina).
• Samples were assessed for cryptic relatedness, excess heterozygosity/ missingness.
• SNPs with MAF<1%, and/or not in HWE were removed, leaving 181,323 SNPs.
• The dataset was imputed using the 1000 Genomes Project; SNPs with r 2 threshold≥0.8 were retained.
• SNPs were tested for association with BMD using PLINK, assessed separately for each control group. 
